1.Epidemic situation and prevention strategy of schistosomiasis in Ya’an City after Lushan Earthquake on April 20,2013
Baohua XU ; Qifu ZHOU ; Zisong WU ; Yakang YANG ; Zhiyong XIAO ; Chengxiang WANG ; Mingkang XIE ; Yanxia WANG ; Yimei ZHANG ; Liang XU ; Bo ZHONG
Chinese Journal of Schistosomiasis Control 2014;(2):209-210,214
This paper analyzes the recently epidemic status of schistosomiasis,the change of natural and social factors,and field survey and evaluation data of schistosomiasis in Ya’an City after Lushan Earthquake on April 20,2013,and proposes that it is necessary to strengthen the conventional schistosomiasis control measures,the control of exogenous infection sources,the con-trol of Oncomelania hupensis snails and health education for ensuring no major epidemics after the disaster. This paper also recom-mends the direction and suggestions for future schistosomiasis control in Ya’an City.
2.Research on standard management for quality and safety of outpatient prescription
Jiancun ZHEN ; Wei ZHANG ; Ping LIN ; Jin LU ; Mingkang ZHONG ; Peiyuan XIA ; Liyan MIAO ; Xiaoyang LU ; Ling JIANG ; Guang DU ; Xuehua JIANG
Chinese Journal of Hospital Administration 2018;34(12):1009-1013
Medication safety is a top concern for medical institutions. Outpatient prescription standard is designed to standardize prescription, dispensing, and supervision for outpatient and emergency prescriptions at medical institutions. The standard covered prescription authorization management, prescription issuance, prescription dispensing, prescription saving and supervision. These four parts focus on risk exposure of patients′medication safety, and aim at safeguarding patient medication safety, which were formulated according to China′s laws and regulations, domestic and international industrial standards and technical specifications, as well as prescription conditions at medical institutions and experts opinions. The standard covers technical requirements and guidance, management measures and system development, serving as an important basis to guide medical institutions on standardize management of outpatient prescription and emergency prescription.
3. Advances in clinical research on drug-induced acute interstitial nephritis
Mingkang ZHANG ; Yanrong MA ; Yongwen JIN ; Yan ZHOU ; Ruirui CUI ; Xin'an WU ; Mingkang ZHANG ; Ruirui CUI ; Xin'an WU ; Mingkang ZHANG ; Yanrong MA ; Yongwen JIN ; Yan ZHOU ; Ruirui CUI ; Xin'an WU
Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(4):419-428
The kidneys are one of the main excretory organs for drugs and when drugs are not excreted effectively, they can accumulate in the kidneys or in the interstitial tubules, leading to drug-induced kidney injury. The tubulointerstitium accounts for 80% of the volume of the kidney and is the primary site of response to various types of renal injury. This article focuses on drug-induced acute interstitial nephritis, highlighting its clinical symptoms, listing common induction drugs, analysing pathological features, and explaining its pathogenesis from the perspective of immune response, with the aim of providing a basic and clinical evidence for subsequent studies.